Discussion about this post

User's avatar
SaHiB's avatar

Because they're bribed to. Pharmas pay cost of evaluating drug applications. That seems to mean approve* if the FDA want any more such grants.

* Though only of the application paperwork, not the drug itself, in the case of Comirnaty.

Expand full comment
JustANobody's avatar

Great Substack. I wholeheartedly agree!

Expand full comment
2 more comments...

No posts